XSTOQCORE
Market cap1mUSD
Dec 23, Last price
5.10SEK
1D
0.99%
1Q
-15.00%
IPO
-89.84%
Name
Qlucore AB (publ)
Chart & Performance
P/E
—
P/S
1.43
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
—
Rev. gr., 5y
-0.71%
Revenues
14m
+13.39%
Net income
-16m
L-1.60%
CFO
-17m
L+110.57%
Profile
Qlucore AB (publ) provides bioinformatics data analysis tools for research and precision diagnostics in Sweden and internationally. Its products include Qlucore Omics Explorer, a bioinformatics AI software for research in life science, biotech, food, and plant industries, as well as academia; Qlucore Diagnostics, a software platform for multi-omics companion and precision diagnostics; and Qlucore Insights, a software for clinical data analysis. Qlucore AB (publ) was incorporated in 2007 and is headquartered in Lund, Sweden.
Valuation
Title SEK in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|
| 2024‑04 | 2023‑04 | 2022‑04 | 2021‑04 | 2020‑04 | 2019‑04 | |
| Income | ||||||
Revenues | 14,369 13.39% | 12,672 -10.24% | 14,118 9.08% | |||
Cost of revenue | 6,971 | 10,309 | 28,380 | |||
Unusual Expense (Income) | ||||||
NOPBT | 7,398 | 2,363 | (14,262) | |||
NOPBT Margin | 51.49% | 18.65% | ||||
Operating Taxes | 27 | 35 | 31 | |||
Tax Rate | 0.36% | 1.48% | ||||
NOPAT | 7,371 | 2,328 | (14,293) | |||
Net income | (15,681) -1.60% | (15,936) 36.64% | (11,663) 93.26% | |||
Dividends | ||||||
Dividend yield | ||||||
Proceeds from repurchase of equity | 67 | 85,556 | ||||
BB yield | -0.12% | -75.05% | ||||
| Debt | ||||||
Debt current | (251) | 1,275 | 875 | |||
Long-term debt | 2,000 | 3,183 | 4,458 | |||
Deferred revenue | ||||||
Other long-term liabilities | (3,183) | (4,458) | ||||
Net debt | (26,870) | (65,274) | (92,636) | |||
| Cash flow | ||||||
Cash from operating activities | (16,949) | (8,049) | (6,806) | |||
CAPEX | (192) | (19,015) | (8,950) | |||
Cash from investing activities | (22,522) | (19,015) | (8,949) | |||
Cash from financing activities | (1,275) | (808) | 86,254 | |||
FCF | 7,496 | 2,398 | (14,588) | |||
| Balance | ||||||
Cash | 28,619 | 69,732 | 97,969 | |||
Long term investments | ||||||
Excess cash | 27,901 | 69,098 | 97,263 | |||
Stockholders' equity | 765 | (37,210) | (21,315) | |||
Invested Capital | 81,528 | 136,401 | 137,209 | |||
ROIC | 6.76% | 1.70% | ||||
ROCE | 8.99% | 2.38% | ||||
| EV | ||||||
Common stock shares outstanding | 4,028 | 4,028 | 4,028 | |||
Price | 7.85 -41.42% | 13.40 -52.65% | 28.30 | |||
Market cap | 31,620 -41.42% | 53,976 -52.65% | 113,994 | |||
EV | 4,750 | (11,297) | 21,358 | |||
EBITDA | 11,434 | 6,103 | (10,763) | |||
EV/EBITDA | 0.42 | |||||
Interest | 353 | 297 | 140 | |||
Interest/NOPBT | 4.77% | 12.57% | ||||